Company*
(Country;
Symbol)

Company

Type/Product Area

Terms/Details (Date)


Metabolic
Research Inc.
(OTC BB:MTBR)

David Summers and T.W. Owen

Exclusive license agreement for technologies relating to the use of fungi, plants and/ or animals for the production of anti-inflammatory and analgesic products for treating inflammatory diseases

Worldwide licenses were gained in exchange for 2.5M shares to the two technology developers (5/7)

Phyton
Biotech
Inc.*

The Dow Chemical Co.

Phyton acquired a technology and intellectual property platform for the engineering of glycosylation in pharmaceutical protein products, namely the humanizing of monoclonal antibodies

Financial terms were not disclosed (5/3)

Reliance
Life
Sciences*
(India)

MPM Capital LP BioVentures IV

Partnership to build India's life sciences sector, with Reliance becoming a limited partner in MPM

The deal will target a portion of the fund's international allocation to invest in emerging life science companies in India (4/26)


Notes:
* Private companies are indicated with an asterisk.
Unless otherwise noted, the trading symbols listed for public companies are on the Nasdaq market.
OTC BB = Over-the-Counter Bulletin Board.

No Comments